MedTrace Logo

PEN Implementation Study

NCT05880784 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2023-08-29

No results posted yet for this study

Summary

There is a gap in the implementation of PEN services as well as in the monitoring and evaluation of the WHO PEN in Nepal. One reason for such gaps is due to a lack of team-based care in low-resource settings like Nepal. Both peer coaching and clinical audit have been shown to be cost-effective ways to improve NCD care. However, no data is available regarding its implementation and outcome. Besides, there is a lack of a proven module of peer coaching and clinical audit for effective NCD care implementation. To address this gap, the investigators designed an intervention to reinforce peer coaching and clinical audit practices in health facilities to improve WHO PEN implementation for better NCD management in Nepal.

Aims of Implementation Research

* To assess implementation outcomes (acceptability, adoption, feasibility, penetration, cost and sustainability) of onsite-peer coaching and clinical audit reinforcement intervention on PEN Program implementation at primary healthcare centers.
* To evaluate the effectiveness of onsite-peer coaching and clinic audit reinforcement intervention in PEN program delivery at health facilities.
* To identify barriers and enabling factors impacting the adoption of onsite-peer coaching and clinical audit in the implementation of the PEN program.

Conditions

  • Package of Essential Non-Communicable Diseases (PEN)
  • Peer Coaching
  • Clinical Audit
  • Mixed Method Implementation Study

Interventions

OTHER

Reinforcement of Peer coaching and clinical audit

The goal of the proposed research study is to test the effectiveness and feasibility of an intervention to enhance peer coaching and clinic audit activities to facilitate the implementation of the Package of Essential Non- Communicable Diseases (PEN) in Nepal.

OTHER

Continuation of usual practice without intervention

No intervention will be carried out, instead usual practice will be evaluated at the start and the end of the study period.

Sponsors & Collaborators

  • Kathmandu University School of Medical Sciences

    collaborator OTHER

  • Shahid Gangalal National Heart Centre

    lead OTHER

Principal Investigators

  • Dipanker Prajapati, MBBS, MD · Shahid Gangalal National Heart Centre, Kathmandu, Nepal

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05880784 on ClinicalTrials.gov